Credit Suisse analyst Jailendra Singh upgraded his rating on Teladoc's stock from neutral to outperform and boosted his price forecast from $225 to $249. Singh's new target price represents potential gains of roughly 25% for investors, based on Teladoc's current price near $200.
https://www.fool.com/investing/2020/08/17/why...ped-today/
After that Teladoc stock....205....went up 18 dollars so far.
Reason I bring this up is because of our Wellness TELEDOC Subsidiary....Telehealth is booming. Lets go Doc, Unleash the Beast. WE BELIEVE IN DOC.
https://www.fool.com/investing/2020/08/17/why...ped-today/
After that Teladoc stock....205....went up 18 dollars so far.
Reason I bring this up is because of our Wellness TELEDOC Subsidiary....Telehealth is booming. Lets go Doc, Unleash the Beast. WE BELIEVE IN DOC.
5